Silvia Galvan

891 total citations
18 papers, 709 citations indexed

About

Silvia Galvan is a scholar working on Epidemiology, Oncology and Immunology. According to data from OpenAlex, Silvia Galvan has authored 18 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Oncology and 7 papers in Immunology. Recurrent topics in Silvia Galvan's work include Cervical Cancer and HPV Research (6 papers), T-cell and B-cell Immunology (4 papers) and Immune Cell Function and Interaction (3 papers). Silvia Galvan is often cited by papers focused on Cervical Cancer and HPV Research (6 papers), T-cell and B-cell Immunology (4 papers) and Immune Cell Function and Interaction (3 papers). Silvia Galvan collaborates with scholars based in Mexico, Italy and United Kingdom. Silvia Galvan's co-authors include Jaime Berúmen, Alejandro Garcı́a-Carrancá, Renato Zambello, Livio Trentin, Carlo Agostini, Marta Siviero, Gianpietro Semenzato, Eduardo Lazcano, G. Gonzalez‐Lira and Elsa Yunes and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Investigation and Blood.

In The Last Decade

Silvia Galvan

18 papers receiving 696 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Silvia Galvan Mexico	10	371	225	209	200	133	18	709
Kirsten M. Edwards Australia	8	567 1.5×	320 1.4×	275 1.3×	159 0.8×	444 3.3×	12	1.1k
Emily Farmer United States	14	253 0.7×	353 1.6×	161 0.8×	65 0.3×	188 1.4×	25	706
Ilvars Silins Sweden	16	338 0.9×	174 0.8×	294 1.4×	240 1.2×	337 2.5×	23	967
Koji Yamanegi Japan	18	340 0.9×	289 1.3×	422 2.0×	180 0.9×	348 2.6×	64	1.1k
M. C. Jendro Germany	13	81 0.2×	352 1.6×	174 0.8×	130 0.7×	114 0.9×	22	867
Margaret Duggan‐Keen United Kingdom	14	600 1.6×	615 2.7×	186 0.9×	186 0.9×	192 1.4×	23	1.1k
Schnürch Hg Germany	7	574 1.5×	117 0.5×	202 1.0×	224 1.1×	140 1.1×	23	869
Pradip N. Akolkar United States	18	235 0.6×	796 3.5×	123 0.6×	93 0.5×	177 1.3×	37	1.2k
Gary S. Hogge United States	8	388 1.0×	327 1.5×	90 0.4×	139 0.7×	88 0.7×	12	937
Steven P. Tjong‐A‐Hung Netherlands	13	432 1.2×	79 0.4×	133 0.6×	228 1.1×	134 1.0×	17	642

Countries citing papers authored by Silvia Galvan

Since Specialization

Citations

This map shows the geographic impact of Silvia Galvan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Galvan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Galvan more than expected).

Fields of papers citing papers by Silvia Galvan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Galvan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Galvan. The network helps show where Silvia Galvan may publish in the future.

Co-authorship network of co-authors of Silvia Galvan

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Galvan. A scholar is included among the top collaborators of Silvia Galvan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Galvan. Silvia Galvan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

1.

Ratti, Chiara, Laura Botti, Valeria Cancila, et al.. (2017). Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors. Clinical Cancer Research. 23(17). 5149–5161. 64 indexed citations

2.

Galvan, Silvia, et al.. (2017). PISMA: A Visual Representation of Motif Distribution in DNA Sequences. Bioinformatics and Biology Insights. 11. 3743677290–3743677290. 3 indexed citations

3.

Galvan, Silvia, Alejandro García Carrancá, Jiuzhou Song, & Félix Recillas‐Targa. (2015). Epigenetics and animal virus infections. Frontiers in Genetics. 6. 48–48. 7 indexed citations

4.

Méndez‐Martínez, Rocío, Norma E. Rivera-Martínez, Brenda Crabtree‐Ramírez, et al.. (2014). Multiple human papillomavirus infections are highly prevalent in the anal canal of human immunodeficiency virus-positive men who have sex with men. BMC Infectious Diseases. 14(1). 671–671. 37 indexed citations

5.

Galvan, Silvia, et al.. (2011). Analysis of CpG methylation sites and CGI among human papillomavirus DNA genomes. BMC Genomics. 12(1). 580–580. 12 indexed citations

6.

Carrancá, Alejandro García & Silvia Galvan. (2007). Vaccines against human papillomavirus: perspectives for controlling cervical cancer. Expert Review of Vaccines. 6(4). 497–510. 3 indexed citations

7.

Berúmen, Jaime, Eduardo Lazcano, Jorge Salmerón, et al.. (2001). Asian-American Variants of Human Papillomavirus 16 and Risk for Cervical Cancer: a Case-Control Study. JNCI Journal of the National Cancer Institute. 93(17). 1325–1330. 236 indexed citations

8.

Agostini, Carlo, Monica Facco, Marta Siviero, et al.. (2000). CXC Chemokines IP-10 and Mig Expression and Direct Migration of Pulmonary CD8 + /CXCR3 + T Cells in the Lungs of Patients with HIV Infection and T-Cell Alveolitis. American Journal of Respiratory and Critical Care Medicine. 162(4). 1466–1473. 90 indexed citations

9.

Trentin, Livio, Alessandra Perin, Marta Siviero, et al.. (2000). B7 costimulatory molecules from malignant cells in patients with B-cell chronic lymphoproliferative disorders trigger T-cell proliferation. Cancer. 89(6). 1259–1268. 20 indexed citations

10.

Zambello, Renato, Livio Trentin, Monica Facco, et al.. (2000). Analysis of TNF-receptor and ligand superfamily molecules in patients with lymphoproliferative disease of granular lymphocytes. Blood. 96(2). 647–654. 9 indexed citations

11.

Zambello, Renato, Livio Trentin, Monica Facco, et al.. (2000). Analysis of TNF-receptor and ligand superfamily molecules in patients with lymphoproliferative disease of granular lymphocytes. Blood. 96(2). 647–654. 13 indexed citations

12.

Galvan, Silvia, et al.. (1999). Asian-American variants of human papillomavirus type 16 have extensive mutations in theE2 gene and are highly amplified in cervical carcinomas. International Journal of Cancer. 83(4). 449–455. 61 indexed citations

13.

Trentin, Livio, Carlo Agostini, Francesco Piazza, et al.. (1999). The chemokine receptor CXCR3 is expressed on malignant B cells and mediates chemotaxis. Journal of Clinical Investigation. 104(1). 115–121. 127 indexed citations

14.

Galvan, Silvia, et al.. (1999). Asian‐American variants of human papillomavirus type 16 have extensive mutations in the E2 gene and are highly amplified in cervical carcinomas. International Journal of Cancer. 83(4). 449–455. 2 indexed citations

15.

Galvan, Silvia, et al.. (1991). Nucleotide sequences of the six very small molecules ofTrypanosoma cruziribosomal RNA. Nucleic Acids Research. 19(9). 2496–2496. 7 indexed citations

16.

Galvan, Silvia, et al.. (1986). Stagewise decline in the activity of brain protein synthesis factors and relationship between this decline and longevity in two rodent species. Mechanisms of Ageing and Development. 36(2). 197–210. 10 indexed citations

17.

Galvan, Silvia, et al.. (1983). Phenetic variation in Trypanosoma (schizotrypanum) cruzi isolates. Comparative Biochemistry and Physiology Part B Comparative Biochemistry. 74(3). 573–578. 7 indexed citations

18.

Galvan, Silvia, et al.. (1982). A Simple Device for Teaching Population Growth. School Science and Mathematics. 82(2). 99–108. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact